Clinical Trial Results: Pharmacokinetic Study for IV Allopregnanolone [Phase 2]

View source ↗

Summary

A Phase 2 pharmacokinetic study of intravenous allopregnanolone for post-traumatic stress disorder was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Allopregnanolone (allopregnanolone)

Snippet

Sponsor: Boston University | Conditions: Pharmacokinetic Study, Post Traumatic Stress Disorder | Phase 2 | Status: TERMINATED | Results posted: 2026-06-02